Efavirenz, the first drug in Thailand approved by the WHO for the second time.



[ad_1]

Efavirenz Antiretroviral drugs against HIV / AIDS The first drug in Thailand that who Accreditation No. 2

Dr. Withoon Danwibun, Director of the Pharmaceutical Organization, revealed that Efavirenz Compressed 600 mg from the Pharmaceutical Organization (Orphanage), which is produced at the Rangsit 1 Drug Factory, Khlong 10, Thanyaburi, Thailand. Pathum Thani received the WHO International Standard Prequalification Program (WHO PQ) In Geneva Switzerland Earlier this week

Efavirenz Tablets 600 mg is the first drug in Thailand. And it is the only country in the member states of Southeast Asia (ASEAN) that has certified said international standard That this is the second time

The certification that must be done every 3 years ago Efavirenz On the WHO Prequalified List on the website of who Considered that the organization has consistently developed and maintained quality standards also

Efavirenz tablets, 600 mg. FDA approved. WHO-PQ First time in late 2018, making FDA able to register drug formula Efavirenz In other countries, it is faster, which can be exported to other countries.

Also, the Government Pharmaceutical Organization There are plans to register 3 types of antiviral drugs against HIV / AIDS in the same tablet, consisting of Dolutegravir 50 mg / Tenofovir DF 300 mg / Lamivudine 300 mg in 2022. If approved, it will be a medicine. Another item that has been certified to world class standards.

“The research, development, and production of Efavirenz is one of the most important examples of generic drug production that the FDA has certified to meet global standards. Generic drugs in the essential drug groups are an important mechanism of Thai public health system, which allows Thai people to have access to medicines that are more effective than conventional ones, due to the fall in price, therefore, it is necessary for the pharmacist to do research, to develop generics in advance because when the Original drug runs out of patents Patients can continue to use generics at a reduced price right away. “

Dr. Por Mukdawan Assembly The deputy director of the Pharmaceutical Organization said that during 2005, ARV Efavirenz Tablets 600 mg is an indispensable medicine for people with HIV. Since it is the first-line regimen that doctors recommend for treatment in Thailand and worldwide.

In November 2006, the Thai government announced the use of a patent (CL) (Compulsory License) that allows more people with HIV access to this drug. Initially, the drug was imported from India at a price agreed in CL’s announcement. At the same time, the pharmacist conducted research and development. Parallel to prepare your own production as a generic medicine

Year 2015 Medicine Efavirenz That the pharmacist has successfully researched, developed and produced has been registered by the Food and Drug Administration (Fda) It can be used to treat HIV / AIDS patients at a price that is cheaper than the imported CL ad price, which has been used continuously from then until now.

[ad_2]